BIOXYNE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 AUD | 0.00% |
|
-16.67% | -54.55% |
| 14/05 | Bioxyne to Release Shares from Escrow; Shares Up 17% | MT |
| 14/05 | Bioxyne Subsidiary, CY Biopharma Enter Partnership to Advance Novel Psilocybin Therapies in Australia | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 6.79M | - | - | - | - | - | |
| 54.63B | - | |||||
| 39.92B | ||||||
| 38.82B | ||||||
| 26.86B | ||||||
| 26.22B |
- Stock Market
- Equities
- BXN Stock
- Charts Bioxyne Limited
- Sector Chart
